Sage Journals: Discover world-class research

Abstract

The aim of this study was to evaluate the influence of nimodipine on non-migrainous vascular headache in patients with chronic cerebral ischemia. Eighty-six patients were examined in a double-blind trial for 16 weeks (12 weeks of nimodipine or placebo, followed by a 4-week placebo period). Fifty-six patients were studied in an open trial for 12 months. In the total material of the double-blind study there was no difference as far as improvement of headache was concerned when comparing the patients treated with nimodipine with those receiving placebo. However, in a group of 38 patients with a higher degree of headache intensity, selected in accordance with the Sandoz Clinical Assessment Geriatric scale, a statistically significant difference was found in favor of nimodipine. The results obtained in the long-term open trial seem to confirm the effect of nimodipine on headache. The underlying mechanisms of the beneficial effect of the drug have been discussed.

Keywords

Chronic cerebral ischemia nimodipine non-migrainous vascular headache

Get full access to this article

View all access options for this article.

References

1. Amery

. Brain hypoxia: the turning-point in the genesis of the migraine attack? Cephalalgia 1982;2:83–109

2. Kazda

Garthoff

Krause

Schlossmann

. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivate Nimodipine in animal experiments. Drug Res 1982;32:331–8

3. Meyer

St. Calcium antagonists and the prophylactic treatment of migraine and cluster headache. In: Lechner

Ladurner

eds Progress in pathophysiology, diagnosis and therapy of cerebrovascular diseases. Amsterdam: Excerpta Medica 1984:85–110

4. Meyer

St . Nimodipine is effective in prophylactic treatment of migraine and cluster headaches. Abstracts of the first international Nimotop symposium. Munich 1984

5. Gelmers

. Nimodipine (a calcium antagonist) in migraine prophylaxis (a double blind, randomized study). Abstracts of the first international Nimotop symposium. Munich 1984

6. Ad hoc committee on classification of headache. Classification of headache. Arch Neurol 1962;6:173–6

7. Hachinski

Linnette

Zilhka

Cerebral blood flow in dementia. Arch Neurol 1972;32:632–7

8. Shader

Harmatz

Salzman

. A new scale for clinical assessment in geriatric populations: Sandoz clinical assessment geriatric (SCAG). J Am Geriatr Soc 1974;22:107–13

9. Hadjiev

. Nimodipine in cerebrovascular insufficiency. In: Lechner

Ladurner

eds Progress in pathophysiology, diagnosis and therapy of cerebrovascular diseases. Amsterdam: Excerpta Medica 1984:117–26

Nimodipine in the Treatment of Headache in Chronic Cerebral Ischemia

Abstract

Keywords

Get full access to this article

References